The objectives of this study were to investigate the relation of vascular, neuropsychiatric, social, and frailty-related factors with "Cognitive impairment, no dementia" (CIND) 
O ver the last decade, a great amount of scientific effort has focused on early detection of Alzheimer disease (AD). Individuals who develop a degenerative dementia are likely to undergo a transitional period of cognitive deficits. The concept of cognitive impairment in nondemented subjects has been raised, and different definitions with variable prognosis have been used. 1 Proposed terms such as "cognitive impairment, no dementia" (CIND) 2, 3 and "mild cognitive impairment" (MCI) 4 describe cognitive syndromes with high rates of progression to dementia and AD. A clinic-based study reported an annual progression rate to AD of 12% for MCI subjects in contrast to an annual incidence of dementia of 2% in cognitively intact subjects. 4 Similar data were obtained from population-based studies conducted in subjects with CIND. 3, 5 However, as previously reported, 6, 7 we also found that the outcome of CIND includes even improvement and that subjects who improved no longer had an increased risk of developing dementia when subsequently followed for three years. 3 These findings suggest that cognitive impairment has heterogenous risk factors. A comprehensive study of risk factors for cognitive impairment in nondemented subjects may help in better understanding this heterogeneity, but few studies have prospectively addressed this issue on a population level. Older age, low education, being black, depression, apolipoprotein E 4 allele (ApoE 4), medicated hypertension, midlife elevated serum cholesterol, high diastolic blood pressure, cortical atrophy, brain infarcts, and white matter hyperintensities have been identified as risk factors for cognitive impairment in dementia-free persons. 8 -11 Within the Kungsholmen Project, we had the opportunity to investigate the longitudinal association among genetic, clinical, neuropsychiatric, and social factors and subsequent development of CIND in an elderly population and to examine whether the associations were independent of future development of AD. Four research hypotheses, each representing possible underlying pathophysiological mechanisms of CIND apart from incipient AD (i.e., conversion within three years), are examined.
Frailty Hypothesis
Because frailty-related factors are associated with low cognitive performance or cognitive impairment, 12, 13 we hypothesized that physical dependence, chronic disease, hip fracture, visual and hearing problems, being underweight, and polypharmacy are risk factors for CIND.
Vascular Hypothesis
Vascular diseases and factors (e.g., ApoE 4) have been reported to be associated with cognitive impairment and cognitive decline in nondemented subjects. 8 -11,14 We hypothesized that heart disease, cerebrovascular disease, hypertension, diabetes, obesity, and ApoE 4 increase the risk of CIND.
Neuropsychiatric Hypothesis
Because depressive symptoms and use of psychotropic drugs have been associated with cognitive decline and cognitive impairment, 8, 13, 15, 16 we hypothesized that psychoses, depressive symptoms, and the use of psychotropic drugs may lead to CIND.
Social Hypothesis
Recent evidence suggests that a socially integrated lifestyle in late life has a beneficial effect on cognition. 17 We hypothesized that infrequent participation in leisure activities and a limited social network increase the risk of developing CIND.
METHODS

Study Population
Data were gathered from the Kungsholmen Project, a longitudinal study of aging and dementia, including all inhabitants of the Kungsholmen district of Stockholm, aged 75ϩ years on October 1, 1987. 18 Among the 1,700 baseline participants (1987) (1988) (1989) , 225 subjects were prevalent dementia cases and 1,475 were nondemented. 18, 19 Of those, 212 subjects had CIND, 31 had low cognitive performance (MiniMental State Examination [MMSE] score Ͻ20), 20 and nine were excluded because of missing data on ed-ucation or age Ͼ95 years. Thus, the cognitively intact cohort at baseline consisted of 1,223 individuals. 3 Of these, 143 moved or refused to attend the first follow up, which was carried out three years later (1991) (1992) (1993) , 21 218 persons died before the examination, and 144 developed dementia. The remaining 718 nondemented subjects constituted the study population. The Karolinska Institutet Ethics Committee approved all phases of the Kungsholmen Project, and written informed consent was obtained from all participants at baseline after the procedures had been fully explained.
Definition of Cognitive Impairment
CIND was defined on the basis of the MMSE. 20 Cutoffs for CIND were derived from a previous study 3 and defined as one standard deviation (SD) below the age-and education-specific mean on the test.
Baseline Variables
Demographics, Lifestyles, and Functional Characteristics. Data on age and sex were obtained from the Stockholm municipality office. Education was measured by total years of formal schooling and dichotomized into Ͻ8 years and Ն8 years. Leisure activities included social, mental, productive, and fitness activities. 22 Social network comprised elements of marital status, living arrangements, having children, frequency of contact, and satisfaction with such contact. 23 Functional status was measured by Katz' index of activity of daily living (ADL). 24 Sensory function was assessed by physician; hearing impairment was defined as being unable to hear the interviewer's voice (even with a hearing aid), and vision impairment included being blind or almost blind.
Clinical Characteristics and ApoE Genotyping. Information on medical drug use in the 2 weeks before the baseline interview was collected and verified by inspecting drug containers and prescriptions. Drugs were coded according to the Anatomical Therapeutical Classification system (ATC). 1. "Vascular disease" included the presence of at least one of heart disease, cerebrovascular disease, diabetes, or hypertension. Diabetes mellitus was defined as the use of blood glucoselowering medications (ATC code: A10) or a previous diagnosis of diabetes in the inpatient registry. Hypertension was defined as a previous diagnosis in the inpatient registry or according to blood pressure measurements taken at baseline (systolic blood pressure Ն160 mm Hg or diastolic blood pressure Ն95 mm Hg). 2. "Chronic disease" included the presence of at least one of the diseases included in the "vascular disease" group or chronic obstructive pulmonary disease, anemia, malignancy, or arthritis.
The presence of current depressive symptoms was assessed by asking the subjects the following questions: "Do you often feel in a low mood?" and "Do you often feel lonely/lonesome?" Both questions belong to the Center for Epidemiological StudiesDepression Scale.
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Body mass index (BMI) was calculated as the body weight (in kilograms) divided by the square height (in meters). Genomic DNA was extracted from peripheral blood samples, and ApoE genotyping was carried out using a standard polymerase chain reaction.
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Diagnosis of Dementia and Alzheimer Disease
For baseline and all follow ups, dementia cases were ascertained by specialists according to Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised criteria 30 with a three-step diagnostic procedure. 18 Briefly, two examining physicians independently made a preliminary diagnosis, and a third opinion was sought in case of disagreement. The AD diagnosis required gradual onset, progressive deterioration, and lack of any other specific cause of dementia. For deceased subjects, dementia diagnoses were made after reviewing the medical records and death certificates.
Statistical Analysis
Characteristics between subjects with and without CIND at first follow up were compared with twotailed Pearson chi-squared or independent Student t tests. The progression rates of CIND to AD were calculated as number of events divided by personyears of follow up. A Cox proportional hazard model was constructed to estimate the relative risk (RR) and 95% confidence intervals (95% CIs) of developing AD related to CIND. Different logistic regression models were constructed to estimate odds ratios (ORs) and 95% CIs of CIND related to each risk factor examined in the different hypotheses.
Frailty Hypothesis. Putative risk factors were ADL disability (a score Ն1), chronic disease, hip fracture, visual and hearing impairment, being underweight, and number of drugs used. BMI was categorized as underweight (BMI Ͻ18.5 kg/m 2 ), normal weight or overweight (BMI 18.5-29.9 kg/m 2 ), or obese (BMI Ն30 kg/m 2 ). 31 BMI was available for 675 (94%) participants. Number of drugs was categorized as no drug use, 1-4 drugs, and polypharmacy (Ն5 drugs).
Vascular Hypothesis. Variables included ApoE 4, heart disease, cerebrovascular disease, hypertension, diabetes, and obesity. ApoE genotypes were available for 626 (87.2%) persons.
Neuropsychiatric Hypothesis. Factors included psychoses, depressive symptoms, and psychotropic drug use. For depressive symptoms, a combined dichotomized variable was created, in which having none of both symptoms was coded as 0 and having one or two symptoms was coded as 1. Drugs included neuroleptics (ATC code: N05A), anxiolytics (ATC code: N05B), other tranquilizers and hypnotics (ATC code: N05C), and antidepressants (ATC code: N06A).
Social Hypothesis. Variables included social, mental, productive, and fitness activities and social network. Concerning leisure activities, participation in mental and fitness activities was dichotomized into frequent (daily) versus no/infrequent (no/less than daily). 22 Participation in social and productive activities was dichotomized into frequent (daily/weekly) versus no/infrequent (no/less than weekly). 22 The previously used four-grade social network summary index was dichotomized into moderate/extensive versus poor/limited social network. 23 For each hypothesis, three different logistic regression models were initially implemented: the unadjusted model; the basic-adjusted model with age, sex, education, and time to first follow-up; and the multiple-adjusted model with further control for confounders specific to each hypothesis. In the last model age, sex, education, and time to first follow up represented common confounders for the four research hypotheses. Further factors entered in the frailty hypothesis as confounders were depressive symptoms, social network, and ApoE 4; specific confounders for the vascular hypothesis were depressive symptoms, chronic obstructive pulmonary disease, anemia, malignancy, and arthritis; for the neuropsychiatric hypothesis, confounders were social network, ApoE 4, ADL disability, and chronic disease; specific confounders for the social hypothesis were depressive symptoms, ADL disability, and chronic disease.
Finally, we further adjusted for the development of AD at the second follow up (three years after CIND occurrence, 1994 -1996) to verify whether the effect of various factors was independent of the ADtype neurodegenerative process. As a result of refusal at second follow up (Nϭ41) and exclusion of other dementias (Nϭ26), the study sample for these analyses consisted of 651 (90.7%) subjects.
Because the results from the unadjusted and basicadjusted models overlapped with those from the multiple-adjusted models, we report only the results from the latter.
RESULTS
Of the 718 subjects that were cognitively intact at baseline, 82 (11.4%) developed CIND at first follow up. The mean follow-up time was 3.4 years (SD: 0.5) without significant difference between subjects with (3.3Ϯ0.5 years) and without (3.4Ϯ0.5 years) CIND (Student t-test 716 ϭ Ϫ1.192; pϭ0.23). At baseline, subjects who developed CIND at first follow up were older and more often reported no/infrequent social and mental activities than cognitively intact subjects (Table 1) .
Individuals with CIND had significantly higher prevalence of hip fracture and psychoses and more often used polypharmacy or had depressive symptoms than subjects without CIND ( Table 2) .
Among the 82 CIND subjects, 20 were diagnosed with AD at the second follow up, with a crude incidence rate of 11.6 per 100 person-years. Of the 636 subjects without CIND, 66 had AD at the second follow up, with a crude incidence rate of 4.0 per 100 person-years. Subjects with CIND had an age, sex, and education adjusted RR of 2.8 (95% CI: 1.7-4.6; Wald 2 [1] ϭ 16.7; p Ͻ0.0001) to develop AD. The mean follow-up time for the 651 subjects followed at the second follow up was 2.7 years (SD: 0.9) with a significant difference between subjects with (2.4Ϯ1.0 years) and without (2.8 Ϯ 0.9 years) CIND at first follow up (Student t-test [649] ϭϪ2.993; p ϭ0.004).
Frailty Hypothesis
Hip fracture and polypharmacy were associated with nearly a threefold increase in the risk of developing CIND, even after controlling for future development of AD (Table 3) .
Vascular Hypothesis
None of the vascular risk factors from the hypothesis were significantly associated with the development of CIND, even after adjustment for subsequent development of AD (Table 4) .
Neuropsychiatric Hypothesis
Previous psychoses increased the risk of CIND nearly sevenfold. Adjustment for future development of AD did not significantly alter this result (Table 5 ). Depressive symptoms increased the risk of CIND. However, when subsequent development of AD was entered in the model, this association was no longer significant (Table 5) .
Social Hypothesis
No/infrequent social activities almost increased the risk of CIND, but this was no longer significantly present when future AD was entered in the model (Table 5) .
DISCUSSION
This study confirms that CIND is characterized by heterogenous risk factors. 8, 10 Psychoses, polypharmacy, and hip fracture increased the risk 
Risk Factors for Cognitive Impairment, No Dementia
of CIND independently of subsequent development of clinical AD. However, subjects with CIND were at increased risk of developing AD.
These findings suggest that CIND is not only a transitional phase between normal aging and AD, but a syndrome with multiple risk factors. Activities of daily living disability 1.1 (0.6-2.0) 0.1 [1] 0.727 1.2 (0.6-2.2) 0.2 [1] 0.649 Chronic disease 0.7 (0.4-1.1) 2.5 [1] 0.115 0.6 (0.4-1.1) 2.7 [1] 0.099 Hip fracture 2.8 (1.1-6.9) 5.0 [1] 0.026 2.9 (1.1-7.8) 4.3 [1] 0.037 Visual problems 1.0 (0.6-1.6) 0.3 [1] 0.603 1.0 (0.6-1.7) 0.05 [1] 0.817 Hearing problems 0.9 (0.5-1.4) 0.004 [1] 0.950 0.9 (0.6-1.6) Ͻ0.0001 [1] 0.986 Body mass index (kg/m 2 ) Ͻ18.5 0.6 (0.2-2.2) 0.6 [1] 0.432 1.0 (0.3-3.6) Ͻ0.0001 [1] 0.996 18.5-29.9
1.0 1.0 Ն30 1.6 (0.5-4.9) 0.6 [1] 0.439 1.5 (0.4-5.7) 0.4 [1] 0.523 Number of drugs used 0 1.0 1.0 1-4 1.6 (0.8-3.5) 1.7 [1] 0.197 2.1 (0.9-5.0) 2.9 [1] 0.088 Ն5 2.6 (1.1-6.1) 5.0 [1] 0.025 3.1 (1.2-8.0) 5.5 [1] 0.019 a OR was adjusted for age, sex, education, time to first follow up, depressive symptoms, social network, apolipoprotein E 4 allele (any versus no), and other variables listed in the table.
b OR was further adjusted for diagnosis of Alzheimer disease made at the second follow-up.
Frailty Hypothesis
Among the frailty-related factors, only hip fracture and number of drugs significantly increased the risk of CIND after controlling for future AD. Potential mechanisms underlying these findings could be immobility resulting from hip fracture, which can lead to thromboembolic complications resulting in silent brain ischemic infarcts causing cognitive decline. 32 Number of drugs used was associated with an increased risk of developing CIND in a doseresponse manner, because the risk steadily increased from use of 1-4 drugs to Ն5 drugs. Polypharmacy can be considered an index of comorbidity, 33 and our findings of a threefold increased risk for CIND among persons taking Ն5 drugs strengthens previous reports that comorbidity is associated with cognitive performance in nondemented subjects. 12 Another possible explanation is that polypharmacy per se might cause cognitive deficits. Heart disease 1.1 (0.5-2.1) 0.04 [1] 0.833 1.0 (0.5-2.1) 0.001 [1] 0.978 Cerebrovascular disease 1.4 (0.5-3.9) 0.3 [1] 0.559 0.8 (0.2-3.0) 0.1 [1] 0.748 Hypertension 1.2 (0.8-2.0) 0.7 [1] 0.417 1.2 (0.7-1.9) 0.4 [1] 0.547 Diabetes 1.4 (0.4-4.5) 0.3 [1] 0.564 1.1 (0.3-4.2) 0.03 [1] 0.862 Body mass index (kg/m 2 ) Ͻ18.5 0.8 (0.2-2.7) 0.2 [1] 0.691 1.1 (0.3-3.8) 0.1 [1] 0.899 18.5-29.9
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1.0 1.0 Ն30 1.4 (0.4-4.3) 0.3 [1] 0.576 1.4 (0.4-5.2) 0.3 [1] 0.576 Apolipoprotein E 4 allele (any versus no)
1.2 (0.7-2.2) 0.5 [1] 0.470 1.5 (0.8-2.7) 1.6 [1] 0.212 a OR was adjusted for age, sex, education, time to first follow up, depressive symptoms, chronic obstructive pulmonary disease, anemia, malignancy, and arthritis, and other variables listed in the table.
b OR was further adjusted for diagnosis of Alzheimer disease made at the second follow-up. [1] 0.042 Depressive symptoms 1.9 (1.1-3.1) 6.0 [1] 0.015 1.3 (0.8-2.3) 1.0 [1] 0.317 Psychotropic drugs use 0.9 (0.6-1.5) 0.09 [1] 0.770 0.9 (0.5-1.6) 0.07 [1] 0.798 Social hypothesis
No/Infrequent social activities 1.6 (1.0-2.6) 3.6 [1] 0.059 1.4 (0.8-2.3) 1.2 [1] 0.270 No/Infrequent mental activities 1.5 (0.9-2.6) 2.1 [1] 0.151 1.5 (0.8-2.7) 1.6 [1] 0.212 No/Infrequent productive activities 0.8 (0.5-1.4) 0.5 [1] 0.469 0.7 (0.4-1.1) 2.3 [1] 0.132 No/Infrequent fitness activities 0.7 (0.4-1.4) 1.0 [1] 0.322 0.6 (0.3-1.4) 1.4 [1] 0.235 Poor/limited social network 0.8 (0.4-1.5) 0.4 [1] 0.506 0.8 (0.4-1.6) 0.3 [1] 0.562 a Neuropsychiatric hypothesis: OR was adjusted for age, sex, education, time to first follow up, social network, apolipoprotein E 4 allele (any versus no), activities of daily living disability, chronic disease, and other variables listed in the table. Social hypothesis: OR was adjusted for age, sex, education, time to first follow up, depressive symptoms, activities of daily living disability, chronic disease, and other variables listed in the table.
b For both hypotheses, OR was further adjusted for diagnosis of Alzheimer disease made at the second follow-up.
Vascular Hypothesis
No associations were found between vascular risk factors and the development of CIND in contrast to previous studies. 8 -11 This lack of replication might be the result of various reasons. First, the sample size may be not large enough to detect a weak association. Second, previous prospective studies investigating risk factors of MCI were carried out in younger populations. 8 -11 The risk effect of vascular diseases on cognitive impairment may be underestimated in the very old as a result of, for example, selective survival (e.g., very old people with vascular comorbidity might have died during the follow-up period, thus being excluded from the analyses). Third, the inpatient registry system may fail to catch some mild cases of vascular disorders (e.g., heart disease and diabetes), which will lead to a dilution of the estimation of the associations. 34, 35 Fourth, as a result of lack of neuroimaging in our study, the possible effect of silent brain infarctions was not taken into account.
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Neuropsychiatric Hypothesis
Previous psychosis was the major risk factor associated with the development of CIND after controlling for the AD-type neurodegenerative process. Psychotic symptoms and long-term therapy with antipsychotic medication may lead to cognitive impairment and dementia. 13, 36 Depressive symptoms were also related to the development of CIND three years later. These data confirm recent findings of an association between depression and MCI. 8 However, our data show that the effect of depressive symptoms on CIND is dependent on the subsequent development of AD, suggesting that the neurodegenerative process underlying the disease may mediate this association. This finding is in line with previous reports in which depressive symptoms occurring more than 25 years before diagnosis were found to be associated with an increased risk of developing AD. 37 Alternatively, depression may be an early sign of AD and cognitive decline.
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Social Hypothesis
Subjects who engaged less frequently in social and mental activities tended to have an increased risk of developing CIND. However, this trend for an association disappeared after controlling for future development of AD. These findings agree with evidence demonstrating that a healthy social life can protect against the development of dementia. 17, 22, 39 The strengths of our study are the populationbased prospective design, the comprehensive analysis of risk factors organized into different etiologic hypotheses, and the adjustment for multiple potential confounders and the ongoing AD-type neurodegenerative process. However, some methodological issues deserve mentioning. First, CIND was determined in persons aged 75ϩ years at entry. Therefore, our results may not be generalizable to a younger elderly population. Second, information on medical history was mainly taken from the inpatient register system, which would identify more severe cases and miss mild cases. However, our inpatient register covered up to six diseases diagnosed per hospital admission; this may have reduced the possibility of missing information. Third, we could have missed some associations resulting from limited statistical power such as the association with vascular factors. Fourth, CIND was defined according to performance on the MMSE, rather than on clinical judgment, and this could be considered an imprecise measurement of cognitive impairment. However, our previous data showed that this CIND definition significantly predicts dementia over three and six years 3 with a similar proportion of progression rates as other clinical definitions of cognitive impairment. 40 Fifth, because our analyses were exploratory, based on preestablished hypotheses, and run in different models of logistic regression, we did not control for multiple comparisons. Finally, AD was diagnosed according to clinical judgment without autopsy confirmation with uncertainty concerning the rate of diagnostic misclassification.
In conclusion, our study shows that CIND has heterogenous risk factors, in which different pathophysiological mechanisms may be involved. CIND is not only a transitional phase between normal aging and AD, but a syndrome with multiple risk factors in which frailty-related factors and psychiatric disorders seem to play a major role. These findings may have relevant preventive and therapeutic implications. 
